Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. - Wikidata - wikimedia - TriplyDB

Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.

Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.

http://www.wikidata.org/entity/Q34063131

about

Nanoparticles: health effects - pros and cons Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract Nanomedicine in pulmonary delivery Gene transfer into the lung by nanoparticle dextran-spermine/plasmid DNA complexes Next generation delivery system for proteins and genes of therapeutic purpose: why and how?Nanomedicine--challenge and perspectives.Nanochemoprevention by bioactive food components: a perspective.Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.Functionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers.Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles.Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.Polymeric nanoparticles for gene delivery.Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.Gene therapy and wound healing Polymeric nano- and microparticle technologies for oral gene delivery.Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice.Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells.Increased nanoparticle penetration in collagenase-treated multicellular spheroids Promising particle-based vaccines in cancer therapy.Bioengineered nanoparticles for siRNA delivery.Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Self-assembled and nanostructured siRNA delivery systems.Hox transcription factor regulation of adult bone-marrow-derived cell behaviour during tissue repair and regeneration.Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug delivery.Emerging implications of nonmammalian cytosine deaminases on cancer therapeutics.Transport barriers and strategies of antitumor nanocarriers delivery system.Nanomedicine for gene therapy.Microbeads mediated oral plasmid DNA delivery using polymethacrylate vectors: an effectual groundwork for colorectal cancer.Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery.Ultrasonic resonator technology as a new quality control method evaluating gelatin nanoparticles.Heat-inducible amplifier vector for high-level expression of granulocyte-macrophage colony-stimulating factor.Influence of formulation factors on the preparation of zein nanoparticles.Size mapping of electric field-assisted production of polycaprolactone particles.Resonance Raman spectral imaging of intracellular uptake of β-carotene loaded poly(D,L-lactide-co-glycolide) nanoparticles.

P2860

Q23918086-6DABCE9B-91C8-418D-82C9-53108F817A7F Q24610060-064F4AB1-08CC-4166-8BC4-8AB2E54EF34B Q33572981-9E312DCA-49D0-4BC6-86AA-8AA4623DDAB7 Q33960002-BB20341F-F1A3-47B2-9F38-9739505FB5C2 Q34003800-424DE0D0-29E5-488D-BE08-204FF4F90B10 Q34247073-8E1E8B32-5896-443C-8DB3-5BE73F22ED4E Q34355598-97BFE016-F5C7-4B98-953E-EDEE68325174 Q34553476-3DDFFB92-CBF8-4B37-974B-DB21E1F7436F Q35190149-C0CDA333-356A-4D93-94D6-4ACAE01C69E3 Q35828034-75A9F19F-7D6C-4CE3-85E8-A7EEFD783853 Q36002746-57CEC12F-3B69-4FFB-99B7-576DF4F876FE Q36064150-15F963B1-15D9-43B4-AACB-B53AAABB1B6E Q36104491-7F18FD89-BD7B-45BD-ACCE-8FE2F615821F Q36302124-A4225A0B-794A-4E6D-899C-31D0F9D2AD78 Q36460846-60DD8776-107E-43DD-A0FB-A168F188CCF8 Q36585761-65C7CE9D-8304-42A8-844F-923BFD9C43BE Q36727410-B0A9004E-5C91-4A05-ACA4-B4ED9C5DB052 Q36815912-67978B5E-8FB7-4B07-A806-250B7CC7D695 Q36836865-85FD521A-BFE6-4BA9-926B-85CA569D9A1A Q36934007-931649B0-AE7B-4FA8-8F33-6C5752D834D5 Q37065810-FB039C3B-DE25-485F-BC0F-B096F0473E70 Q37171112-C3D45AEE-4D51-4ED2-B688-A81185AE56C9 Q37259642-60A72D98-5815-4316-A2D9-FFD3763D5F31 Q37679156-CEBAC0F2-BA85-492F-8AC7-9383BF45D94A Q37771030-1B8332F2-EE38-453D-968E-735C3957DECD Q37804385-EEAEE433-E74F-4E55-AD3C-0BEC0912294B Q37855596-4E143F5F-5DE6-497D-8D96-8DBD9F304CFF Q37868026-C9D4437B-1AC8-4436-A5A1-40EAFC66D950 Q37960075-1D0EB662-5CC5-4065-AE9A-60BA9A214F02 Q38016754-F01CC66D-E678-43F2-93E5-E69E003F73E6 Q38132105-E558A303-59D1-4A63-BBAE-A38A6A7A9C80 Q38383478-725416FD-0448-41B7-814E-F13E29BE8251 Q39005124-67BBE468-6477-4A38-8075-AB9C6163ABFD Q39017657-4D61604A-7C35-444F-9AE2-C245D18BBCED Q39405505-E7CDC44D-FB3F-46D8-81DB-CA13AEDE2A9D Q39881249-9C580010-A47B-487E-A9A9-4C056E4D94F6 Q40246887-35824A8B-71FC-4521-AD41-77FAD87353FF Q41871672-1BC20C10-C075-4424-ACC6-E3C00D3C88A9 Q42106730-247072DE-14FF-4624-9BD0-2C26D42923AA Q42829700-D9B40AAC-D686-4E32-8693-9396C82FA751

P2860

Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.

http://www.wikidata.org/entity/Q34063131

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Tumor-targeted gene delivery using poly

@nl

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@ast

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@en

type

label

Tumor-targeted gene delivery using poly

@nl

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@ast

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@en

prefLabel

Tumor-targeted gene delivery using poly

@nl

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@ast

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@en

P1433

Q34063131-019CD5C9-EE6C-4365-8145-1CC26C581E75

P1476

Q34063131-C58D17F8-EBC7-43A5-B44C-184C43FF2C35

P2093

Q34063131-2AB5A1F4-5808-4559-938C-81D70469C7A7

Q34063131-C5D8CD70-6DF4-4D44-B62A-3DC52E42BB28

P2860

Q34063131-042EC149-654D-4085-B1D9-2CA377E8D0E5

Q34063131-06CE0B14-7F55-442C-AB6A-21DA9F08F4CA

Q34063131-0DC4C616-FA92-45AD-9293-5BA939CF515F

Q34063131-1D508C88-7DA1-4372-AAEF-839960B00A7B

Q34063131-1E8EFED2-ACCA-467E-BD81-F2E918A4033B

Q34063131-32C1580A-22CC-4279-A205-F9D9B81F0EF1

Q34063131-420EB61B-F986-4E8E-B662-8BFA52992BEA

Q34063131-62967D8E-C92A-48A9-ADD4-488D612CE863

Q34063131-66D3796B-070F-4E3F-A5DD-03FB3FF8FB62

Q34063131-8C76919B-01E7-4120-944B-BC2E429A630E

P304

Q34063131-3FDFE062-6B39-410A-B5D0-46DCB157101E

P31

Q34063131-6B4EB8D6-619E-48C8-B590-0D5D054A2D28

P356

Q34063131-CA7BE89F-CEB3-4012-BE82-5A396F0DF947

P433

Q34063131-A9CB0FAB-41B0-4345-BA6A-B4B0031F29D2

P478

Q34063131-B5A125AB-2A37-4192-A1DD-42F1AC245666

P577

Q34063131-EF27BDA1-60F9-4B73-BE6F-13FDC6F7777B

P5875

Q34063131-A498AC7B-A71B-454A-8F0B-7F2FBA07ACA9

P698

Q34063131-FA711F89-9AD4-47B2-AAA2-781BCDF7711F

P921

Q34063131-EB53A375-91B1-4D14-9497-D370DDE7293D

P932

Q34063131-9645F431-665E-4790-B0D1-8A7AB5445565

P356

S11095-005-4590-3

P1433

Pharmaceutical Research

P1476

Tumor-targeted gene delivery u ...... in vitro and in vivo studies.

@en

P2093

Goldie Kaul

http://www.w3.org/2001/XMLSchema#string

Mansoor Amiji

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting of Synthetic Gene Delivery Systems

Synthetic DNA delivery systems

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

New horizons: gene therapy for cancer.

Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model.

Non-viral vectors in cancer gene therapy: principles and progress.

Long-circulating and target-specific nanoparticles: theory to practice.

Nonviral approaches satisfying various requirements for effective in vivo gene therapy.

Intracellular barriers to non-viral gene transfer.

Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

P304

951-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-005-4590-3

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7794581

http://www.w3.org/2001/XMLSchema#string

P698

15948039

http://www.w3.org/2001/XMLSchema#string

P921

P932

1242175

http://www.w3.org/2001/XMLSchema#string